Managing Your Genetic Health
search
Home
Corporate
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Medical
Overview
Breast & Ovarian Cancer
Bowel & Uterine Cancer
Neurogenetics
Epilepsy
Forensics
Overview
Presumptive & Confirmatory Testing
Individual DNA Profiling
Species Identification
Animal Forensic Testing
Paternity
Legal - Paternity
Non Legal - Paternity
Legal Practitioners
Antenatal
Deceased Estate
DNA In A Day
Sibship
Twins
Y – Chromosome
DNA Profiling
Grandparent
Immigration
Personal
Overview
Sports Performance
Ancestry
Animals
DNA Testing
Frozen Puppies
BITSA
Animal Forensics
Plants
Genomic Services
Xpress Sequencing
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Announcements
BREVAGen data presented at ASCO 2010
08 June 2010
BREVAGen data presented at ASCO 2010
Patent claims upheld in full by USPTO
09 May 2010
Patent claims upheld in full by USPTO
EraGen Biosciences License
05 May 2010
EraGen Biosciences license
Gen-Probe License
03 May 2010
Gen-Probe License
Acquisition of BREVAGen
14 April 2010
Acquisition of BREVAGen
Previous Announcements
Private placement of shares and ASX Appendix 3B
GTG Investor Update - March 2010
NASDAQ press release - 16 March 2010 Marketplace Rule 5810(b)
Expiry of options - 2 March 2010
ASX Appendix 4D - 31 December 2009 with Financial Report
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 2 of 15
Latest News
ASX Quarterly Reports - 30 June 2010
ASX Appendix 3B with covering letter
Transfer to NASDAQ Capital Market
Share Price